Sections
Shows
Events
Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country
Cipla Q4 net profit jumps over two-fold to Rs 357.68 crore; drug major to raise up to Rs 6,000 crore
